Articles by Rachel Grabenhofer

1. The cGMP Reality Of Clinical Supply For Advanced Therapies 5/5/2026

   Breakthrough therapies fail without cGMP‑ready supply. In cell and gene therapies, quality systems, timing, documentation and logistics dictate patient access.

2. Putting Vaccine Supply Resilience To The Test: The Last Mile 4/29/2026

   This second in a two-part series describes how the resilience of a global vaccine network shaped clinical supply is challenged up to the last mile: at clinical sites.

3. How Clinical Supply Drives Resilience In Global Vaccine Networks 4/29/2026

   This article is the first in a two-part series exploring how clinical supply's ability to integrate processes drives resilience in global vaccine programs.

4. 6 Risks To Clinical Supply Spurred By 'Once In A Lifetime' Lp(a) Screening 4/14/2026

   Expert-recommended "once‑in‑a‑lifetime" testing for Lp(a) introduces new clinical supply risks as screening drives volatility, longer treatment, and inventory strain.

5. AI In Clinical Supply – Hype, Hope, And The Path To Predictive Precision 3/20/2026

   Agentic AI offers new hope for predictive precision in clinical supply, but success will depend on data readiness, connected systems, and maintaining human oversight.